Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noha Mousaad Elemam

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Immunotargets and Therapy|March 27, 2020
Role of Chemokines and Chemokine Receptors in Rheumatoid ArthritisNoha Mousaad Elemam, Suad Hannawi, Azzam A Maghazachi
Current Medical Research and Opinion|March 23, 2021
COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remediesNoha Mousaad Elemam, Azzam A Maghazachi, Suad Hannawi
Toxins|December 14, 2017
Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic MoleculesNoha Mousaad Elemam, Suad Hannawi, Azzam A Maghazachi
Computational and Structural Biotechnology Journal|February 9, 2021
Chemokines and chemokine receptors during COVID-19 infectionBariaa A Khalil, Noha Mousaad Elemam, Azzam A Maghazachi
International Journal of Molecular Sciences|June 2, 2021
Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus PatientsNoha Mousaad Elemam, Hind Hasswan, Hayat Aljaibeji, et al.
Frontiers in Immunology|February 17, 2022
Complement System: An Immunotherapy Target in Colorectal CancerIman M Talaat, Noha Mousaad Elemam, Maha Saber-Ayad
Viruses|November 11, 2022
CXCL10 Chemokine: A Critical Player in RNA and DNA Viral InfectionsNoha Mousaad Elemam, Iman Mamdouh Talaat, Azzam A Maghazachi
Journal of Inflammation Research|October 16, 2020
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune EncephalomyelitisSarah Dhaiban, Mena Al-Ani, Noha Mousaad Elemam, et al.
Infection and Drug Resistance|October 16, 2020
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?Mena Al-Ani, Noha Mousaad Elemam, Jennifer Elisabeth Hundt, et al.
Genes|May 6, 2020
Differentially Expressed Genes of Natural Killer Cells Can Distinguish Rheumatoid Arthritis Patients from Healthy ControlsNoha Mousaad Elemam, Mahmood Yaseen Hachim, Suad Hannawi, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Immunotargets and Therapy|March 27, 2020
Role of Chemokines and Chemokine Receptors in Rheumatoid ArthritisNoha Mousaad Elemam, Suad Hannawi, Azzam A Maghazachi
Current Medical Research and Opinion|March 23, 2021
COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remediesNoha Mousaad Elemam, Azzam A Maghazachi, Suad Hannawi
Toxins|December 14, 2017
Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic MoleculesNoha Mousaad Elemam, Suad Hannawi, Azzam A Maghazachi
Computational and Structural Biotechnology Journal|February 9, 2021
Chemokines and chemokine receptors during COVID-19 infectionBariaa A Khalil, Noha Mousaad Elemam, Azzam A Maghazachi
International Journal of Molecular Sciences|June 2, 2021
Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus PatientsNoha Mousaad Elemam, Hind Hasswan, Hayat Aljaibeji, et al.
Frontiers in Immunology|February 17, 2022
Complement System: An Immunotherapy Target in Colorectal CancerIman M Talaat, Noha Mousaad Elemam, Maha Saber-Ayad
Viruses|November 11, 2022
CXCL10 Chemokine: A Critical Player in RNA and DNA Viral InfectionsNoha Mousaad Elemam, Iman Mamdouh Talaat, Azzam A Maghazachi
Journal of Inflammation Research|October 16, 2020
Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune EncephalomyelitisSarah Dhaiban, Mena Al-Ani, Noha Mousaad Elemam, et al.
Infection and Drug Resistance|October 16, 2020
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?Mena Al-Ani, Noha Mousaad Elemam, Jennifer Elisabeth Hundt, et al.
Genes|May 6, 2020
Differentially Expressed Genes of Natural Killer Cells Can Distinguish Rheumatoid Arthritis Patients from Healthy ControlsNoha Mousaad Elemam, Mahmood Yaseen Hachim, Suad Hannawi, et al.
Pageof 4